Clinical Trials

Clinical Trials

R.N.I. participates in clinical studies of new therapies for disease areas.  If there is a study that might be suitable for you, please get in touch with our research coordinators.

Send an e-mail to Leigh Kreshel.

Neurology: Current Clinical Trials Open For Enrollment

New Studies:

MS Study Evaluating Safety and Efficacy of Two Doses of Fingolimod Versus Copaxone

clinical Coordinator –LeAnn Cannon, LPN, CCRC
Phone: 913-827-4261, Email: lcannon@neurokc.com

http://www.clinicaltrial.gov/ct2/show/NCT01633112?term=CFTY720D2312&rank=1



Exploring the Efficacy and Safety of Siponimod in Patients With Secondary Progressive Multiple Sclerosis

Clinical Coordinator – LeAnn Cannon, LPN, CCRC
Phone: 913-827-4261, Email: lcannon@neurokc.com

http://www.clinicaltrial.gov/ct2/show/NCT01665144?term=CBAF312A2304&rank=1


A Clinical Evaluation Of The Safety Of Baclofen Er Capsules (Grs) When Administered Once Daily To Subjects With Spasticity Due To Multiple Sclerosis (MS): An Open Label, Long Term, Safety Trial

Clinical Coordinator – Leigh Kreshel, MS, CCRC
Phone: 913-827-4262, Email: lkreshel@neurokc.com

http://http://www.clinicaltrial.gov/ct2/show/NCT01797185?term=CLR_09_21&rank=1



Efficacy and Safety of Baclofen ER Capsules (GRS) in Subjects With Spasticity Due to Multiple Sclerosis)

Clinical Coordinator – Leigh Kreshel, MS, CCRC
Phone: 913-827-4262, Email: lkreshel@neurokc.com

http://www.clinicaltrial.gov/ct2/show/NCT01457352?term=CLR_09_21&rank=2


Action of Baclofen Capsules in Spasticity Due to Multiple Sclerosis

Clinical Coordinator – Shannon Cone, LPN, CCRC
Phone: 913-827-4260, Email: scone@neurokc.com

For more information, please use the link below:

http://www.clinicaltrial.gov/ct2/show/NCT02027025?term=CLR_11_03&rank=1


A Multicenter Assessment of LBR-101 in High Frequency Episodic Migraine

Clinical Coordinator – Shannon Cone, LPN, CCRC
Phone: 913-827-4260, Email: scone@neurokc.com

http://www.clinicaltrial.gov/ct2/show/NCT02025556?term=labrys+migraine&rank=1


Assessment of LBR-101 in Chronic Migraine

Clinical Coordinator – Shannon Cone, LPN, CCRC
Phone: 913-827-4260, Email: scone@neurokc.com

http://www.clinicaltrial.gov/ct2/show/NCT02021773?term=labrys+migraine&rank=2


Safety Study in Patients With Multiple Sclerosis Treated Fingolimod or Other Approved Disease-modifying Therapies

Clinical Coordinator – LeAnn Cannon, LPN, CCRC
Phone: 913-827-4261, Email: lcannon@neurokc.com

http://www.clinicaltrial.gov/ct2/show/NCT01442194?term=Novartis+Passage&rank=1


Disease Control and Safety in Patients With Relapsing Remitting Multiple Sclerosis (RRMS) Switching From Natalizumab to Fingolimod

Clinical Coordinator – LeAnn Cannon, LPN, CCRC
Phone: 913-827-4261, Email: lcannon@neurokc.com

http://www.clinicaltrial.gov/ct2/show/NCT01499667?term=fingolimod%2C+transitions&rank=1


Effectiveness of DMF and Its Impact on PROs in Suboptimal GA Responders With RMS

Clinical Coordinator – Shannon Cone, LPN, CCRC
Phone: 913-827-4260, Email: scone@neurokc.com

http://www.clinicaltrial.gov/ct2/show/NCT01903291?term=tecfidera%2C+Respond&rank=1


Dimethyl Fumarate (DMF) Observational Study

Clinical Coordinator – Shannon Cone, LPN, CCRC
Phone: 913-827-4260, Email: scone@neurokc.com

http://www.clinicaltrial.gov/ct2/show/NCT02047097?term=tecfidera%2C+Esteem&rank=1

Enjoy the article? Share the link: